Zealand Pharma to Present Data at the American Diabetes Association's 2026/Petrelintide, a Human Amylin Analog for the Treatment of Obesity: Efficacy and Safety from the Phase 2 Trial, ZUPREME 1
Below are some of the most commonly used GLP-1 medications: Dulaglutide (Trulicity) Exenatide (Bydureon BCise) Liraglutide (Saxenda, Victoza) Semaglutide (Ozempic, Rybelsus, Wegovy) Tirzepatide (Mounjaro, Zepbound) These medications differ in their dosing schedules, mechanisms of administration, and specific indications, but all work the same to improve blood sugar levels and support improved long-term health outcomes
Semaglutide dry mouth profile Semaglutide, marketed as Ozempic and Wegovy, carries a reporting-odds ratio of 1.34 for dry mouth in adverse event databases
Semaglutide 2.4mg (Wegovy) is contraindicated in pregnancy, while other GLP-1 receptor agonists are generally not recommended